MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivo

Bibliographic Details
Main Author: Fiedler, L
Format: Journal article
Published: Elsevier 2019
_version_ 1797065679505981440
author Fiedler, L
author_facet Fiedler, L
author_sort Fiedler, L
collection OXFORD
description
first_indexed 2024-03-06T21:32:01Z
format Journal article
id oxford-uuid:44fe1521-8151-4af3-a2aa-dd6676d48410
institution University of Oxford
last_indexed 2024-03-06T21:32:01Z
publishDate 2019
publisher Elsevier
record_format dspace
spelling oxford-uuid:44fe1521-8151-4af3-a2aa-dd6676d484102022-03-26T15:05:05ZMAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivoJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:44fe1521-8151-4af3-a2aa-dd6676d48410Symplectic Elements at OxfordElsevier2019Fiedler, L
spellingShingle Fiedler, L
MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivo
title MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivo
title_full MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivo
title_fullStr MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivo
title_full_unstemmed MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivo
title_short MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivo
title_sort map4k4 inhibition promotes survival of human stem cell derived cardiomyocytes and reduces infarct size in vivo
work_keys_str_mv AT fiedlerl map4k4inhibitionpromotessurvivalofhumanstemcellderivedcardiomyocytesandreducesinfarctsizeinvivo